A legacy of impact
Our scientists have created a therapy against the Ebola virus, discovered an early diagnostic for breast cancer and provided data that brought potentially harmful chemicals in personal-care products to light.
As the premier scientific research institute in the nation’s fastest-growing research university, Biodesign’s impact is accelerating. These are just a handful of ways our research is answering today’s challenges.
|By 2023, Biodesign’s estimated annual impact on Arizona’s economy will reach $2.9 billion.|
|Biodesign has attracted over $760 million in funding from grants as well as philanthropic and industry sources.|
|Scientists at Biodesign are undertaking research in over 200 active research projects.|
Clinical Testing Laboratory
When COVID-19 appeared in Arizona, we sprang into action to protect our community. Biodesign’s Clinical Testing Lab created the first saliva-based COVID-19 PCR test publicly available in the U.S. Today, the lab tracks critical COVID-19 trends and partners with the state to provide public testing.
Spotlight: Award-winning experts
Lynch wins lifetime achievement award
Michael Lynch is the winner of the 2022 Genetics Society of America Thomas Hunt Morgan Medal.
Lim receives faculty research award
Efrem Lim is the recipient of the ASU Alumni Association’s 2022 Faculty Research Achievement Award for sequencing and tracking SARS CoV-2 variants for the state since the start of the pandemic.
ASU researchers named Senior Members of the National Academy of Inventors
The National Academy of Inventors (NAI) has named Arizona State University Deputy Director Stephen Munk and professor Bertram Jacobs to the February 2022 class of Senior Members.